Bioanalytical Services Comprehensive Study by Type (Discovery bioanalysis services, Non-clinical bioanalysis services, Clinical bioanalysis services), Application (Pharmaceutical Industry, Biotechnology, Medical Device Industry), Molecule (Small molecules, Large molecules), Test (ADME {absorption, distribution, metabolism, and excretion}, Pharmacokinetic, Pharmacodynamics, Bioavailability, Bioequivalence, Others) Players and Region - Global Market Outlook to 2027

Bioanalytical Services Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Overview:
Bioanalysis is a branch of analytical chemistry that deals with biological samples for analysis of measurement of biological molecules, DNA, large molecules, and others. Bioanalytical services are specifically applied to toxicology, pharmacology studies, bioequivalence studies, along with pharmacokinetic and bioavailability studies in animals of humans. Bioanalytical services are offered for every phase of drug development, from discovery to clinical development phases. The bioanalytical services market is facing increasing demand in the biotechnology and pharmaceutical industry. The demand is increasing due to the difficulties in conducting these services in-house.



AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies ProfiledCharles River Laboratories International Inc. (United States), LabCorp (United States), WuXi PharmaTech (Cayman) Inc. (China), IQVIA (United States), Eurofins Scientific SE (Luxembourg), Syneos Health (United States), SGS (Switzerland), PPD Inc. (United States), PRA Health Sciences (United States) and BioReliance Corporation (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region or narrow down segments in the final scope subject to feasibility


AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics of major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Key Players of Bioanalytical Services Market Study:
Charles River Laboratories International Inc. (United States), LabCorp (United States), WuXi PharmaTech (Cayman) Inc. (China), IQVIA (United States), Eurofins Scientific SE (Luxembourg), Syneos Health (United States), SGS (Switzerland), PPD Inc. (United States), PRA Health Sciences (United States) and BioReliance Corporation (United States)

Bioanalytical Services Market Segment Analysis
ScopeSub-Segments
Application / End UserPharmaceutical Industry, Biotechnology and Medical Device Industry
TypeDiscovery bioanalysis services, Non-clinical bioanalysis services and Clinical bioanalysis services
MoleculeSmall molecules,Large molecules
TestADME {absorption, distribution, metabolism, and excretion},Pharmacokinetic,Pharmacodynamics,Bioavailability,Bioequivalence,Others


Influencing Trend:
Increase in investment by biopharmaceutical companies in R&D and drug development and Rising trend of outsourcing analytical testing owing to cost effective than in-house R&D

Market Growth Drivers:
Increasing demand for bioanalytical services in the pharmaceutical and biotechnology industry and Increase in incidence of chronic diseases and rise in economic cost

Challenges:
Expensive treatments

Restraints:
Lack of skilled professionals to carry out activities

Opportunities:
Burden of these diseases on health care systems across the world

Some of the other players that are also part of study are Bioclin Research Laboratories, Intertek Group Plc., ICON, Algorithme and Parexel.




Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Bioanalytical Services market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Bioanalytical Services market.
Identification of total players or companies operating in the global market which is further concentrated to fewer or most impacting players which are considered under the report’s scope. In order to make a priority list sorting is done based on revenue generated based on the latest reporting with the help of paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Healthcare Institutions (Hospitals, Medical Schools, and outpatient Clinics), Biopharmaceutical companies, Contract development and manufacturing organization (CDMO), Clinical Research organizations/ contract research organizations, Market Research and Consulting Firms and Venture Capitalists and Investors.

This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Discovery bioanalysis services
  • Non-clinical bioanalysis services
  • Clinical bioanalysis services
By Application
  • Pharmaceutical Industry
  • Biotechnology
  • Medical Device Industry
By Molecule
  • Small molecules
  • Large molecules

By Test
  • ADME {absorption, distribution, metabolism, and excretion}
  • Pharmacokinetic
  • Pharmacodynamics
  • Bioavailability
  • Bioequivalence
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing demand for bioanalytical services in the pharmaceutical and biotechnology industry
      • 3.2.2. Increase in incidence of chronic diseases and rise in economic cost
    • 3.3. Market Challenges
      • 3.3.1. Expensive treatments
    • 3.4. Market Trends
      • 3.4.1. Increase in investment by biopharmaceutical companies in R&D and drug development
      • 3.4.2. Rising trend of outsourcing analytical testing owing to cost effective than in-house R&D
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bioanalytical Services, by Type, Application, Molecule, Test and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Bioanalytical Services (Value)
      • 5.2.1. Global Bioanalytical Services by: Type (Value)
        • 5.2.1.1. Discovery bioanalysis services
        • 5.2.1.2. Non-clinical bioanalysis services
        • 5.2.1.3. Clinical bioanalysis services
      • 5.2.2. Global Bioanalytical Services by: Application (Value)
        • 5.2.2.1. Pharmaceutical Industry
        • 5.2.2.2. Biotechnology
        • 5.2.2.3. Medical Device Industry
      • 5.2.3. Global Bioanalytical Services by: Molecule (Value)
        • 5.2.3.1. Small molecules
        • 5.2.3.2. Large molecules
      • 5.2.4. Global Bioanalytical Services by: Test (Value)
        • 5.2.4.1. ADME {absorption, distribution, metabolism, and excretion}
        • 5.2.4.2. Pharmacokinetic
        • 5.2.4.3. Pharmacodynamics
        • 5.2.4.4. Bioavailability
        • 5.2.4.5. Bioequivalence
        • 5.2.4.6. Others
      • 5.2.5. Global Bioanalytical Services Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Bioanalytical Services (Price)
      • 5.3.1. Global Bioanalytical Services by: Type (Price)
  • 6. Bioanalytical Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Charles River Laboratories International Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. LabCorp (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. WuXi PharmaTech (Cayman) Inc. (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. IQVIA (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eurofins Scientific SE (Luxembourg)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Syneos Health (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. SGS (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PPD Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. PRA Health Sciences (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. BioReliance Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Bioanalytical Services Sale, by Type, Application, Molecule, Test and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Bioanalytical Services (Value)
      • 7.2.1. Global Bioanalytical Services by: Type (Value)
        • 7.2.1.1. Discovery bioanalysis services
        • 7.2.1.2. Non-clinical bioanalysis services
        • 7.2.1.3. Clinical bioanalysis services
      • 7.2.2. Global Bioanalytical Services by: Application (Value)
        • 7.2.2.1. Pharmaceutical Industry
        • 7.2.2.2. Biotechnology
        • 7.2.2.3. Medical Device Industry
      • 7.2.3. Global Bioanalytical Services by: Molecule (Value)
        • 7.2.3.1. Small molecules
        • 7.2.3.2. Large molecules
      • 7.2.4. Global Bioanalytical Services by: Test (Value)
        • 7.2.4.1. ADME {absorption, distribution, metabolism, and excretion}
        • 7.2.4.2. Pharmacokinetic
        • 7.2.4.3. Pharmacodynamics
        • 7.2.4.4. Bioavailability
        • 7.2.4.5. Bioequivalence
        • 7.2.4.6. Others
      • 7.2.5. Global Bioanalytical Services Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Bioanalytical Services (Price)
      • 7.3.1. Global Bioanalytical Services by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bioanalytical Services: by Type(USD Million)
  • Table 2. Bioanalytical Services Discovery bioanalysis services , by Region USD Million (2016-2021)
  • Table 3. Bioanalytical Services Non-clinical bioanalysis services , by Region USD Million (2016-2021)
  • Table 4. Bioanalytical Services Clinical bioanalysis services , by Region USD Million (2016-2021)
  • Table 5. Bioanalytical Services: by Application(USD Million)
  • Table 6. Bioanalytical Services Pharmaceutical Industry , by Region USD Million (2016-2021)
  • Table 7. Bioanalytical Services Biotechnology , by Region USD Million (2016-2021)
  • Table 8. Bioanalytical Services Medical Device Industry , by Region USD Million (2016-2021)
  • Table 9. Bioanalytical Services: by Molecule(USD Million)
  • Table 10. Bioanalytical Services Small molecules , by Region USD Million (2016-2021)
  • Table 11. Bioanalytical Services Large molecules , by Region USD Million (2016-2021)
  • Table 12. Bioanalytical Services: by Test(USD Million)
  • Table 13. Bioanalytical Services ADME {absorption, distribution, metabolism, and excretion} , by Region USD Million (2016-2021)
  • Table 14. Bioanalytical Services Pharmacokinetic , by Region USD Million (2016-2021)
  • Table 15. Bioanalytical Services Pharmacodynamics , by Region USD Million (2016-2021)
  • Table 16. Bioanalytical Services Bioavailability , by Region USD Million (2016-2021)
  • Table 17. Bioanalytical Services Bioequivalence , by Region USD Million (2016-2021)
  • Table 18. Bioanalytical Services Others , by Region USD Million (2016-2021)
  • Table 19. South America Bioanalytical Services, by Country USD Million (2016-2021)
  • Table 20. South America Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 21. South America Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 22. South America Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 23. South America Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 24. Brazil Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 25. Brazil Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 26. Brazil Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 27. Brazil Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 28. Argentina Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 29. Argentina Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 30. Argentina Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 31. Argentina Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 32. Rest of South America Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 33. Rest of South America Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 34. Rest of South America Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 35. Rest of South America Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 36. Asia Pacific Bioanalytical Services, by Country USD Million (2016-2021)
  • Table 37. Asia Pacific Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 38. Asia Pacific Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 39. Asia Pacific Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 40. Asia Pacific Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 41. China Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 42. China Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 43. China Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 44. China Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 45. Japan Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 46. Japan Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 47. Japan Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 48. Japan Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 49. India Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 50. India Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 51. India Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 52. India Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 53. South Korea Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 54. South Korea Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 55. South Korea Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 56. South Korea Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 57. Taiwan Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 58. Taiwan Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 59. Taiwan Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 60. Taiwan Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 61. Australia Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 62. Australia Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 63. Australia Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 64. Australia Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 69. Europe Bioanalytical Services, by Country USD Million (2016-2021)
  • Table 70. Europe Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 71. Europe Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 72. Europe Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 73. Europe Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 74. Germany Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 75. Germany Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 76. Germany Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 77. Germany Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 78. France Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 79. France Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 80. France Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 81. France Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 82. Italy Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 83. Italy Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 84. Italy Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 85. Italy Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 86. United Kingdom Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 87. United Kingdom Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 88. United Kingdom Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 89. United Kingdom Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 90. Netherlands Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 91. Netherlands Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 92. Netherlands Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 93. Netherlands Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 94. Rest of Europe Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 95. Rest of Europe Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 96. Rest of Europe Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 97. Rest of Europe Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 98. MEA Bioanalytical Services, by Country USD Million (2016-2021)
  • Table 99. MEA Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 100. MEA Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 101. MEA Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 102. MEA Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 103. Middle East Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 104. Middle East Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 105. Middle East Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 106. Middle East Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 107. Africa Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 108. Africa Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 109. Africa Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 110. Africa Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 111. North America Bioanalytical Services, by Country USD Million (2016-2021)
  • Table 112. North America Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 113. North America Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 114. North America Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 115. North America Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 116. United States Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 117. United States Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 118. United States Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 119. United States Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 120. Canada Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 121. Canada Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 122. Canada Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 123. Canada Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 124. Mexico Bioanalytical Services, by Type USD Million (2016-2021)
  • Table 125. Mexico Bioanalytical Services, by Application USD Million (2016-2021)
  • Table 126. Mexico Bioanalytical Services, by Molecule USD Million (2016-2021)
  • Table 127. Mexico Bioanalytical Services, by Test USD Million (2016-2021)
  • Table 128. Bioanalytical Services: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Bioanalytical Services: by Type(USD Million)
  • Table 140. Bioanalytical Services Discovery bioanalysis services , by Region USD Million (2022-2027)
  • Table 141. Bioanalytical Services Non-clinical bioanalysis services , by Region USD Million (2022-2027)
  • Table 142. Bioanalytical Services Clinical bioanalysis services , by Region USD Million (2022-2027)
  • Table 143. Bioanalytical Services: by Application(USD Million)
  • Table 144. Bioanalytical Services Pharmaceutical Industry , by Region USD Million (2022-2027)
  • Table 145. Bioanalytical Services Biotechnology , by Region USD Million (2022-2027)
  • Table 146. Bioanalytical Services Medical Device Industry , by Region USD Million (2022-2027)
  • Table 147. Bioanalytical Services: by Molecule(USD Million)
  • Table 148. Bioanalytical Services Small molecules , by Region USD Million (2022-2027)
  • Table 149. Bioanalytical Services Large molecules , by Region USD Million (2022-2027)
  • Table 150. Bioanalytical Services: by Test(USD Million)
  • Table 151. Bioanalytical Services ADME {absorption, distribution, metabolism, and excretion} , by Region USD Million (2022-2027)
  • Table 152. Bioanalytical Services Pharmacokinetic , by Region USD Million (2022-2027)
  • Table 153. Bioanalytical Services Pharmacodynamics , by Region USD Million (2022-2027)
  • Table 154. Bioanalytical Services Bioavailability , by Region USD Million (2022-2027)
  • Table 155. Bioanalytical Services Bioequivalence , by Region USD Million (2022-2027)
  • Table 156. Bioanalytical Services Others , by Region USD Million (2022-2027)
  • Table 157. South America Bioanalytical Services, by Country USD Million (2022-2027)
  • Table 158. South America Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 159. South America Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 160. South America Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 161. South America Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 162. Brazil Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 163. Brazil Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 164. Brazil Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 165. Brazil Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 166. Argentina Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 167. Argentina Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 168. Argentina Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 169. Argentina Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 170. Rest of South America Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 171. Rest of South America Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 172. Rest of South America Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 173. Rest of South America Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 174. Asia Pacific Bioanalytical Services, by Country USD Million (2022-2027)
  • Table 175. Asia Pacific Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 176. Asia Pacific Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 177. Asia Pacific Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 178. Asia Pacific Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 179. China Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 180. China Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 181. China Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 182. China Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 183. Japan Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 184. Japan Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 185. Japan Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 186. Japan Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 187. India Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 188. India Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 189. India Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 190. India Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 191. South Korea Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 192. South Korea Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 193. South Korea Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 194. South Korea Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 195. Taiwan Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 196. Taiwan Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 197. Taiwan Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 198. Taiwan Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 199. Australia Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 200. Australia Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 201. Australia Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 202. Australia Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 203. Rest of Asia-Pacific Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 204. Rest of Asia-Pacific Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 205. Rest of Asia-Pacific Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 206. Rest of Asia-Pacific Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 207. Europe Bioanalytical Services, by Country USD Million (2022-2027)
  • Table 208. Europe Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 209. Europe Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 210. Europe Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 211. Europe Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 212. Germany Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 213. Germany Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 214. Germany Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 215. Germany Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 216. France Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 217. France Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 218. France Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 219. France Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 220. Italy Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 221. Italy Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 222. Italy Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 223. Italy Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 224. United Kingdom Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 225. United Kingdom Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 226. United Kingdom Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 227. United Kingdom Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 228. Netherlands Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 229. Netherlands Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 230. Netherlands Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 231. Netherlands Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 232. Rest of Europe Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 233. Rest of Europe Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 234. Rest of Europe Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 235. Rest of Europe Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 236. MEA Bioanalytical Services, by Country USD Million (2022-2027)
  • Table 237. MEA Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 238. MEA Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 239. MEA Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 240. MEA Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 241. Middle East Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 242. Middle East Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 243. Middle East Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 244. Middle East Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 245. Africa Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 246. Africa Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 247. Africa Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 248. Africa Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 249. North America Bioanalytical Services, by Country USD Million (2022-2027)
  • Table 250. North America Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 251. North America Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 252. North America Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 253. North America Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 254. United States Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 255. United States Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 256. United States Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 257. United States Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 258. Canada Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 259. Canada Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 260. Canada Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 261. Canada Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 262. Mexico Bioanalytical Services, by Type USD Million (2022-2027)
  • Table 263. Mexico Bioanalytical Services, by Application USD Million (2022-2027)
  • Table 264. Mexico Bioanalytical Services, by Molecule USD Million (2022-2027)
  • Table 265. Mexico Bioanalytical Services, by Test USD Million (2022-2027)
  • Table 266. Bioanalytical Services: by Type(USD/Units)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bioanalytical Services: by Type USD Million (2016-2021)
  • Figure 5. Global Bioanalytical Services: by Application USD Million (2016-2021)
  • Figure 6. Global Bioanalytical Services: by Molecule USD Million (2016-2021)
  • Figure 7. Global Bioanalytical Services: by Test USD Million (2016-2021)
  • Figure 8. South America Bioanalytical Services Share (%), by Country
  • Figure 9. Asia Pacific Bioanalytical Services Share (%), by Country
  • Figure 10. Europe Bioanalytical Services Share (%), by Country
  • Figure 11. MEA Bioanalytical Services Share (%), by Country
  • Figure 12. North America Bioanalytical Services Share (%), by Country
  • Figure 13. Global Bioanalytical Services: by Type USD/Units (2016-2021)
  • Figure 14. Global Bioanalytical Services share by Players 2021 (%)
  • Figure 15. Global Bioanalytical Services share by Players (Top 3) 2021(%)
  • Figure 16. Global Bioanalytical Services share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Charles River Laboratories International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Charles River Laboratories International Inc. (United States) Revenue: by Geography 2021
  • Figure 20. LabCorp (United States) Revenue, Net Income and Gross profit
  • Figure 21. LabCorp (United States) Revenue: by Geography 2021
  • Figure 22. WuXi PharmaTech (Cayman) Inc. (China) Revenue, Net Income and Gross profit
  • Figure 23. WuXi PharmaTech (Cayman) Inc. (China) Revenue: by Geography 2021
  • Figure 24. IQVIA (United States) Revenue, Net Income and Gross profit
  • Figure 25. IQVIA (United States) Revenue: by Geography 2021
  • Figure 26. Eurofins Scientific SE (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 27. Eurofins Scientific SE (Luxembourg) Revenue: by Geography 2021
  • Figure 28. Syneos Health (United States) Revenue, Net Income and Gross profit
  • Figure 29. Syneos Health (United States) Revenue: by Geography 2021
  • Figure 30. SGS (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. SGS (Switzerland) Revenue: by Geography 2021
  • Figure 32. PPD Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. PPD Inc. (United States) Revenue: by Geography 2021
  • Figure 34. PRA Health Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 35. PRA Health Sciences (United States) Revenue: by Geography 2021
  • Figure 36. BioReliance Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 37. BioReliance Corporation (United States) Revenue: by Geography 2021
  • Figure 38. Global Bioanalytical Services: by Type USD Million (2022-2027)
  • Figure 39. Global Bioanalytical Services: by Application USD Million (2022-2027)
  • Figure 40. Global Bioanalytical Services: by Molecule USD Million (2022-2027)
  • Figure 41. Global Bioanalytical Services: by Test USD Million (2022-2027)
  • Figure 42. South America Bioanalytical Services Share (%), by Country
  • Figure 43. Asia Pacific Bioanalytical Services Share (%), by Country
  • Figure 44. Europe Bioanalytical Services Share (%), by Country
  • Figure 45. MEA Bioanalytical Services Share (%), by Country
  • Figure 46. North America Bioanalytical Services Share (%), by Country
  • Figure 47. Global Bioanalytical Services: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Charles River Laboratories International Inc. (United States)
  • LabCorp (United States)
  • WuXi PharmaTech (Cayman) Inc. (China)
  • IQVIA (United States)
  • Eurofins Scientific SE (Luxembourg)
  • Syneos Health (United States)
  • SGS (Switzerland)
  • PPD Inc. (United States)
  • PRA Health Sciences (United States)
  • BioReliance Corporation (United States)
Additional players considered in the study are as follows:
Bioclin Research Laboratories , Intertek Group Plc. , ICON , Algorithme , Parexel
Select User Access Type

Key Highlights of Report


Nov 2023 224 Pages 65 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increase in investment by biopharmaceutical companies in R&D and drug development " is seen as one of major influencing trends for Bioanalytical Services Market during projected period 2021-2027.
The Concentration Rate of Global Bioanalytical Services market is highlighted using HHI Index.
Players will contribute the maximum growth of Global Bioanalytical Services market throughout the predicted period.

Know More About Global Bioanalytical Services Report?